In fall of 2019, Granger Smith was diagnosed with a rare, progressive neuromuscular disease called spinal muscular atrophy just days after he was born. At six weeks old, he became the first child at UK HealthCare to receive a brand-new FDA-approved treatment for this disease and today, Granger is an active preschooler who inspires his family and providers.
↧